CompletedNot Applicable

Patient Navigator Intervention for Diabetic Retinopathy

United States35 participantsStarted 2022-07-25

Plain-language summary

This is a pilot study of a patient navigator intervention for people living with diabetes and at high risk of diabetic blindness. The investigators are assessing the feasibility and acceptability of the intervention in preparation for a clinical trial.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 18 and over * Diagnosis of diabetes and record of diagnosis in YNHHS EPIC * English-speaking * No documented eye examination within 1 year of study enrollment * High risk for diabetic retinopathy based on risk calculator evaluation Exclusion Criteria: * Documented eye exam in the past year * Not high risk for diabetic retinopathy * Diabetes diagnosis not recorded in EPIC

What they're measuring

Number of Participant Who Had Baseline Eye Exam

Timeframe: baseline

Percentage of Participants Who Completed a Follow-up Eye Exam 12-18 Months After Baseline Eye Exam

Timeframe: up to 18 month

Trial details

NCT IDNCT05188703

SponsorYale University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-19

Results submitted2025-09-16

View on ClinicalTrials.gov More Diabetic Retinopathy trials